Applications Open for the 2021 AIM-HI Women’s Venture Competition!
Today is International Women’s Day. In honor of the occassion, [...]
Winner of the AIM-HI Accelerator Fund’s Inaugural Women’s Venture Competition Announced
Privo Technologies to Receive $900,000 of Investment Funding Privo Technologies and [...]
Oncoheroes & SHEPHERD Therapeutics United Against Rare Cancers
On Childhood Cancer Day, SHEPHERD Therapeutics is joining forces with Oncoheroes Biosciences to bring [...]
Together, All of Our Actions Matter!
Every year, people around the world connect on a special [...]
Oncoheroes Biosciences Secures Additional Venture Philanthropy Investment
An additional venture philanthropy organization, the Catalytic Impact Foundation, which [...]
SciTech Development Presenting at the 2021 China BioMed Forum during the 39th J.P. Morgan Healthcare Conference
The AIM-HI Accelerator Fund is proud to support our Portfolio [...]
AIM-HI Women’s Venture Competition Sponsor: Microsoft
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Tvardi Therapeutics Awarded “Most Promising” Company at the 2020 Texas Life Science Forum
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Oncoheroes Biosciences’ Pediatric Cancer Drug Candidate Receives Orphan Drug Designation
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
Congratulations to our Top Two Finalists and the People’s Choice Award Winner!
Gravida ultricies interdum risus adipiscing non. Ornare leo eu imperdiet.
